- $2.17bn
- $2.38bn
- $1.06bn
- 43
- 51
- 55
- 48
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.52 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2.06 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -9.92% | ||
| Return on Equity | -12.64% | ||
| Operating Margin | -17.92% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 212.52 | 377.22 | 667.51 | 859.54 | 1,055.66 | 1,220.15 | 1,380.62 | 49.29% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
LifeStance Health Group, Inc. is a mental healthcare company. The Company is focused on providing of virtual and in-person outpatient mental health care for children, adolescents and adults experiencing a variety of mental health conditions. Its clinicians provide services spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. The Company treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. It uses evidence-based approaches to ensure effective treatment. The Company offers patients the ability to conduct a given visit with their clinician virtually. It has around 6,645 employed psychiatrists, APNs, psychologists, and therapists. It employs approximately 6,600 psychiatrists, advanced practice nurses, psychologists and therapists and operates across 33 states and more than 550 centers.
Directors
- Michael Lester CHM (65)
- J. Michael Bruff CFO (52)
- Gwendolyn Booth COO (49)
- Warren Gouk CAD (49)
- Felicia Gorcyca OTH (42)
- Kevin Mullins OTH (36)
- Pablo Pantaleoni OTH (33)
- Anisha Patel-dunn OTH (45)
- Danish Qureshi OTH (37)
- Ryan Pardo SEC (45)
- Robert Bessler IND (49)
- Darren Black IND (49)
- Jeffrey Crisan IND (47)
- William Miller IND (54)
- Jeffrey Rhodes IND (46)
- Eric Shuey IND (53)
- Katherine Wood IND (36)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- January 28th, 2021
- Public Since
- June 10th, 2021
- No. of Shareholders
- 52
- No. of Employees
- 9,325
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
NASDAQ Global Select Market- Shares in Issue
- 380,689,929
- Address
- 4800 N. Scottsdale Road, Suite 6000, SCOTTSDALE, 85251
- Web
- https://investor.lifestance.com/
- Phone
- +1 6027672100
- Contact
- Monica Prokocki
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for LFST
Q1 2024 Lifestance Health Group Inc Earnings Release
Lifestance Health Group Inc Annual Shareholders Meeting
Q2 2024 Lifestance Health Group Inc Earnings Release
Similar to LFST
23andMe Holding Co.
NASDAQ Global Select Market
Acadia Healthcare
NASDAQ Global Select Market
Accolade
NASDAQ Global Select Market
Addus HomeCare
NASDAQ Global Select Market
Alignment Healthcare
NASDAQ Global Select Market
FAQ
What is the Lifestance Health share price?
As of Today at 19:25 UTC, shares in Lifestance Health are trading at $5.71. This share price information is delayed by 15 minutes.
How has the Lifestance Health share price performed this year?
Shares in Lifestance Health last closed at $5.71 and the price had moved by -27.45% over the past 365 days. In terms of relative price strength the Lifestance Health share price has underperformed the S&P500 Index by -39.62% over the past year.
What are the analyst and broker recommendations for Lifestance Health?
The overall consensus recommendation for Lifestance Health is Hold. You can view the full broker recommendation list by unlocking its StockReport.
What is the Lifestance Health dividend yield?
Lifestance Health does not currently pay a dividend.
Does Lifestance Health pay a dividend?
Lifestance Health does not currently pay a dividend.
When does Lifestance Health next pay dividends?
Lifestance Health does not currently pay a dividend.
How do I buy Lifestance Health shares?
To buy shares in Lifestance Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Lifestance Health?
As of the previous close price of $5.71, shares in Lifestance Health had a market capitalisation of $2.17bn.
Where are Lifestance Health shares listed?
Here are the trading details for Lifestance Health:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: LFST
What kind of share is Lifestance Health?
Based on an overall assessment of its quality, value and momentum Lifestance Health is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Lifestance Health share price forecast for 2024?
The analyst consensus target price for shares in Lifestance Health is $8.79. That is 53.94% above the last closing price of $5.71.
Analysts covering Lifestance Health currently have a consensus Earnings Per Share (EPS) forecast of -$0.28 for the next financial year.
What is the trend in the Lifestance Health share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Lifestance Health. Over the past six months, its share price has underperformed the S&P500 Index by -9.56%.
As of the last closing price of $5.71, shares in Lifestance Health were trading -18.42% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Lifestance Health PE Ratio?
The Lifestance Health PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $5.71.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Lifestance Health?
Lifestance Health's management team is headed by:
- Michael Lester - CHM
- J. Michael Bruff - CFO
- Gwendolyn Booth - COO
- Warren Gouk - CAD
- Felicia Gorcyca - OTH
- Kevin Mullins - OTH
- Pablo Pantaleoni - OTH
- Anisha Patel-dunn - OTH
- Danish Qureshi - OTH
- Ryan Pardo - SEC
- Robert Bessler - IND
- Darren Black - IND
- Jeffrey Crisan - IND
- William Miller - IND
- Jeffrey Rhodes - IND
- Eric Shuey - IND
- Katherine Wood - IND